Evidence map›Paper›PMID 28770445›Full record

ArticleAntonie van Leeuwenhoek2017

Actinoalloteichus fjordicus sp. nov. isolated from marine sponges: phenotypic, chemotaxonomic and genomic characterisation.

Imen Nouioui, Christian Rückert, Joost Willemse, Gilles P van Wezel, Hans-Peter Klenk, Tobias Busche, Jörn Kalinowski, Harald Bredholt, Sergey B Zotchev

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antonie van Leeuwenhoek, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Imen NouiouiSchool of Biology, Newcastle University, Newcastle upon Tyne, NE1 7RU, UK.
Christian RückertMicrobial Genomics and Biotechnology, Center for Biotechnology (CeBiTec), Bielefeld University, 33594, Bielefeld, Germany.
Joost WillemseMolecular Biotechnology, Sylvius Laboratories, Leiden University, 2333BE, Leiden, The Netherlands.
Gilles P van WezelMolecular Biotechnology, Sylvius Laboratories, Leiden University, 2333BE, Leiden, The Netherlands.
Hans-Peter KlenkSchool of Biology, Newcastle University, Newcastle upon Tyne, NE1 7RU, UK.
Tobias BuscheMicrobial Genomics and Biotechnology, Center for Biotechnology (CeBiTec), Bielefeld University, 33594, Bielefeld, Germany.
Jörn KalinowskiMicrobial Genomics and Biotechnology, Center for Biotechnology (CeBiTec), Bielefeld University, 33594, Bielefeld, Germany.
Harald BredholtXellia Pharmaceuticals, Silurveien 2, 0380, Oslo, Norway.
Sergey B ZotchevDepartment of Pharmacognosy, University of Vienna, Althanstraße 14, 1090, Vienna, Austria. sergey.zotchev@univie.ac.at.ORCID http://orcid.org/0000-0002-9324-245X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two actinobacterial strains, ADI 127-17

Indexed as

ActinobacteriaAnimalsBacterial Typing TechniquesComputational BiologyGenes, BacterialGenome, BacterialGenomicsHigh-Throughput Nucleotide SequencingMetabolomicsMolecular Sequence AnnotationMultigene FamilyPhenotypePhylogenyPoriferaSecondary MetabolismActinoalloteichusActinobacteriaChemotaxonomyComparative genomicsMarine spongesNew speciesSecondary metabolite biosynthesis gene clusters

Identifiers

PMID28770445
PMCPMC5676828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.